BSD Medical to Present at The 16th Annual Rodman & Renshaw Global Investment Conference on September 10, 2014
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The investor conference is being held September 8-10, 2014 at The Palace Hotel in New York City.
William Barth, BSD Medical’s Chief Financial Officer, will provide an overview of BSD’s business during a live presentation on Wednesday, September 10 at 1:15pm. Mr. Barth will also be available to participate in one-on-one meetings with institutional investors who are registered to attend the conference. Interested investors should contact the conference organizers, or BSD Medical investor relations at email@example.com.
Event: 16th Annual Rodman & Renshaw Global Investment Conference
When: September 10, 2014
Time: 1:15 p.m. (Eastern Time)
Location: Kennedy II Salon (4th Floor); The Palace Hotel in New York City
A copy of BSD Medical’s powerpoint presentation will be available for the public to access via the Investor Relations section of the Company’s corporate website.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused microwave energy and radiofrequency (RF). BSD’s product lines include ablation and hyperthermia treatment systems. BSD’s microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The Company has developed extensive intellectual property, multiple products in the market, and well established distribution in the United States, Europe and Asia. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. Certain of the Company’s products have received regulatory approvals in the United States, Europe and China. For further information visit BSD Medical’s website at www.BSDMedical.com.
Sorry. No data so far.